None
Quote | SPDR S&P Pharmaceuticals (NYSE:XPH)
Last: | $39.442 |
---|---|
Change Percent: | -0.87% |
Open: | $39.74 |
Close: | $39.79 |
High: | $39.74 |
Low: | $39.442 |
Volume: | 3,809 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
News | SPDR S&P Pharmaceuticals (NYSE:XPH)
First Quarter 2024 Highlights: Sales of $3.26 billion, up 9% in U.S. dollars and 6% organically compared to the first quarter of 2023 GAAP Diluted EPS of $0.87, up 23% compared to prior year Adjusted Diluted EPS of $0.80, up 16% compared to prior year GAAP and Adjusted...
Amphenol Corporation (NYSE: APH) today released its 2023 Sustainability Report. “Amphenol continues to make a positive impact on the environment, the communities in which we operate and our global team members, all while delivering exceptional performance for our shareholders,” ...
Message Board Posts | SPDR S&P Pharmaceuticals (NYSE:XPH)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
SPDR S&P Pharmaceuticals Company Name:
XPH Stock Symbol:
NYSE Market:
First Quarter 2024 Highlights: Sales of $3.26 billion, up 9% in U.S. dollars and 6% organically compared to the first quarter of 2023 GAAP Diluted EPS of $0.87, up 23% compared to prior year Adjusted Diluted EPS of $0.80, up 16% compared to prior year GAAP and Adjusted...
Amphenol Corporation (NYSE: APH) today released its 2023 Sustainability Report. “Amphenol continues to make a positive impact on the environment, the communities in which we operate and our global team members, all while delivering exceptional performance for our shareholders,” ...
2024-04-09 09:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...